Overnight Health Care — Presented by Alexion — Pfizer effectiveness drops in younger kids
Welcome to Monday's Overnight Health Care, where we’re following the latest moves on policy and news affecting your health.
Stay updated with breaking news from Genevant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Welcome to Monday's Overnight Health Care, where we’re following the latest moves on policy and news affecting your health.
(Reuters) - Arbutus Biopharma Corp said on Monday it had filed a lawsuit against Moderna Inc seeking damages for infringement of patents related to it...
Breaking News, Latest News and Current News from OANN.com. Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.
By Josh Beckerman Roivant Sciences Ltd. shares recently traded up 28% to $14.02, following gains in the previous four sessions. The biotechnology company didn't appear to issue any press... | December 20, 2021
By Baek Byung-yeul, Kim Yoo-chul Korean biotechnology firm, ST Pharm, is in talks with Moderna to produce messenger RNA (mRNA) COVID-19 vaccines, sources familiar with the matter told The Korea Times, Tuesday. "ST Pharm is in talks with Moderna to produce its mRNA vaccines following approval by the Ministry of Food and Drug Safety," one source said on condition of anonymity. ST Pharm declined to comment on the possibility of signing a contract manufacturing organization (CMO) deal with Moderna. "ST Pharm plans to apply liquid nanoparticle (LNP)-based drug substance technology for its RNA va...